Premium
Treatment of lipoid proteinosis with ablative Er:YAG laser resurfacing
Author(s) -
Çalıskan Ercan,
Açıkgöz Gürol,
Tunca Mustafa,
Koç Erol,
Arca Ercan,
Akar Ahmet
Publication year - 2015
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12247
Subject(s) - medicine , scars , genodermatosis , ablative case , dermatology , er:yag laser , ablation , surgery , laser , radiation therapy , biochemistry , chemistry , physics , optics , gene
Lipoid proteinosis (LP) is a rare autosomal recessive genodermatosis characterized by deposition of amorphous hyaline material in different parts of the body, especially the skin and mucous membranes. Disfiguring lesions predominantly affect facial appearance. There is no curative therapy and treatment options are limited to symptomatic approaches. Facial disfigurement in this disease may have an huge negative effect on the patients’ psychology and quality of life. With this regard, the patients may benefit very much from symptomatic treatments. Four patients with LP were treated with Er:YAG laser to ablate disfiguring lesions on the face. Patients were followed up for 14 months to 2 years. We obtained favorable clinical and aesthetic results in all cases with Er:YAG laser treatment and did not observe any recurrences during the follow‐up. Depending on our observations Er‐YAG laser can be accepted as an effective tool for dermal accumulations and scars of LP with precise ablation capability and favorable esthetic results.